申请人:Johnson James Andrew
公开号:US20110172191A1
公开(公告)日:2011-07-14
A series of thieno[2,3-b]pyridine derivatives, attached at the 2-position to a substituted anilino moiety, which are substituted in the 3-position by a carbonyl group linked to a pyrrolidin-1-yl ring which in turn forms part of a heteroatom-containing fused bicyclic ring system, being selective inhibitors of human MEK (MAPKK) enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, proliferative (including oncological) and nociceptive conditions.
一系列的thieno[2,3-b]pyridine衍生物,附着在取代的苯胺基上的2位置,其在3位置被一个羰基基团取代,该羰基基团与一个吡咯烷-1-基环相连,该环反过来构成一个含有杂原子的螺环系统,这些衍生物是选择性抑制人类MEK(MAPKK)酶的,因此在医学上具有益处,例如用于治疗炎症、自身免疫、心血管、增生性(包括肿瘤)和疼痛性疾病。